Dr Reddy's Acquires Johnson & Johnson's Stugeron Brand for Vertigo Treatment

Dr Reddy's Laboratories has acquired the Stugeron brand from Johnson & Johnson for the treatment of vertigo. The brand contains Cinnarizine, an antihistamine indicated for vestibular disturbances and vertigo. The acquisition will strengthen Dr Reddy's CNS portfolio and expand its footprint in the anti-vertigo space. The company plans to extend the reach of Stugeron across 18 key markets in the APAC and EMEA regions, including India and Vietnam.